文献速递呼吸道感染呼吸危重症与机械通气

重型COVID-19炎症反应特征分析

Characterization of the Inflammatory Response to Severe COVID-19 Illness.
PubMed 文献 · Am J Respir Crit Care Med · 2020-01-01

该研究对比健康志愿者、普通住院COVID-19患者、需ICU治疗的COVID-19患者及需ICU的重症社区获得性肺炎患者的血浆细胞因子谱,发现COVID-19细胞因子血症有别于其他肺炎,重症患者中性粒细胞存在免疫代谢重编程,IL-6:AAT比值可预测ICU延长和死亡。

要点

  • COVID-19细胞因子血症特征区别于其他肺炎,与器官衰竭和ICU需求相关。
  • 重症COVID-19中性粒细胞发生免疫代谢重编程,PKM2、HIF-1α和乳酸升高。
  • IL-6:AAT比值在需ICU的COVID-19患者中显著升高,可预测不良结局。

核心结论

  • COVID-19细胞因子血症有别于其他类型肺炎,可导致器官衰竭和ICU需求。
  • 重症COVID-19中性粒细胞发生免疫代谢重编程。
  • 细胞因子比值可能预测该人群的结局。

研究设计与样本

  • 研究评估健康志愿者、COVID稳定患者、COVID ICU患者和CAP ICU患者血浆中IL-1β、IL-6、IL-8、IL-10和sTNFR1水平。
  • 检测重症COVID-19患者循环中性粒细胞的免疫代谢标志物。
  • 评估AAT对COVID-19的急性期反应。

主要发现

  • COVID-19患者IL-1β、IL-6、IL-8和sTNFR1均升高。
  • COVID ICU患者可与COVID稳定患者明确区分,且较CAP ICU患者IL-1β、IL-6和sTNFR1更高而IL-10更低。
  • COVID-19中性粒细胞胞浆PKM2、磷酸化PKM2、HIF-1α和乳酸增加。
  • COVID-19中AAT产生和唾液酸化增加,但重症时该抗炎反应被压倒,需ICU患者IL-6:AAT比值显著更高(P < 0.0001)。
  • 重症COVID-19患者IL-6:AAT升高预测ICU延长和死亡,IL-6:AAT改善与临床缓解相关(P < 0.0001)。

临床怎么用

  • 细胞因子谱尤其是IL-6:AAT比值可用于重症COVID-19风险分层和预后监测。
  • 重症COVID-19中性粒细胞免疫代谢重编程提示潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Coronavirus disease (COVID-19) is a global threat to health. Its inflammatory characteristics are incompletely understood.Objectives: To define the cytokine profile of COVID-19 and to identify evidence of immunometabolic alterations in those with severe illness.Methods: Levels of IL-1β, IL-6, IL-8, IL-10, and sTNFR1 (soluble tumor necrosis factor receptor 1) were assessed in plasma from healthy volunteers, hospitalized but stable patients with COVID-19 (COVIDstable patients), patients with COVID-19 requiring ICU admission (COVIDICU patients), and patients with severe community-acquired pneumonia requiring ICU support (CAPICU patients). Immunometabolic markers were measured in circulating neutrophils from patients with severe COVID-19. The acute phase response of AAT (alpha-1 antitrypsin) to COVID-19 was also evaluated.Measurements and Main Results: IL-1β, IL-6, IL-8, and sTNFR1 were all increased in patients with COVID-19. COVIDICU patients could be clearly differentiated from COVIDstable patients, and demonstrated higher levels of IL-1β, IL-6, and sTNFR1 but lower IL-10 than CAPICU patients. COVID-19 neutrophils displayed altered immunometabolism, with increased cytosolic PKM2 (pyruvate kinase M2), phosphorylated PKM2, HIF-1α (hypoxia-inducible factor-1α), and lactate. The production and sialylation of AAT increased in COVID-19, but this antiinflammatory response was overwhelmed in severe illness, with the IL-6:AAT ratio markedly higher in patients requiring ICU admission (P < 0.0001). In critically unwell patients with COVID-19, increases in IL-6:AAT predicted prolonged ICU stay and mortality, whereas improvement in IL-6:AAT was associated with clinical resolution (P < 0.0001).Conclusions: The COVID-19 cytokinemia is distinct from that of other types of pneumonia, leading to organ failure and ICU need. Neutrophils undergo immunometabolic reprogramming in severe COVID-19 illness. Cytokine ratios may predict outcomes in this population.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. McElvaney OJ, McEvoy NL, McElvaney OF, et al. Characterization of the Inflammatory Response to Severe COVID-19 Illness. Am J Respir Crit Care Med. 2020. PMID: 32584597. doi:10.1164/rccm.202005-1583OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。